Muscle Fatigue and Cognition: What is the Link?

14 days had no beneficial effects (Figure 1), and may have caused muscle fatigue. In fact, the control group showed a trend toward better performance, suggesting that long-term injection of AICAR may have bi-directional effects on cognition, similar to exercise (Akerström and Pedersen, 2007). These results are supported by finding that short-term AICAR treatment promoted sirtuin 1 protein expression in skeletal muscle, whereas 14 days did not (Suwa et al., 2011). Given the fact that intracerebral infusion of AICAR impaired memory function (Dash et al., 2006) and that AICAR has a very low ability to cross the blood brain barrier (BBB), estimated at <1% (Marangos et al., 1990), it is likely that the beneficial effects of AICAR on the brain are indirect. Indeed, when administered peripherally, AICAR and GW may lead to release of factors from muscle into circulation that can cross the BBB and enhance cell genesis. Thus, similar to differential effects of moderate and high intensity exercise, AICAR improved memory and neurogenesis in a dose dependent way. Prolonged administration of AICAR may result in harmful neural responses, similar to overtraining. We hypothesize that mechanisms contributing to muscle damage after strenuous exercise may be the same as those that could be caused by high doses of AICAR. Free oxygen radicals are generated during exercise as a side product of oxidative metabolism. In particular, increased production of nitric oxide (NO) derivates is a desired consequence of exercise for proper muscle function but higher levels of NO can cause contractile dysfunction, resulting in muscle fatigue. Strenuous exercise can accelerate the generation of NO to levels that result in oxidative stress (Nikolaidis et al., 2008), sustained for days after exercise (Appell et al., 1992). NO induces mitochondria biogenesis in skeletal muscle via upregulation of PGC1α, and interacts with AMPK. Pharmacological activation of AMPK with AICAR and the subsequent induction of GLU4 are blunted by inhibition of NO bance of the contractile apparatus of the gastrocnemius muscle. The mitochondria in skeletal muscle fibers can show focal swelling and crystalline inclusions. Cell necrosis is evident 7 days after the race (Appell et al., 1992). Furthermore, as little as 10 days of increased training may result in over-reaching (Armstrong and VanHeest, 2002). What are the mechanisms underlying effects of overtraining on CNS? We propose that there is a strong link between factors mediating muscle endurance and brain function that may help explain the consequences of muscle fatigue on cognition. We recently demonstrated that peripheral endurance related factors lead to improved spatial memory in sedentary mice, suggesting that skeletal muscle activation by exercise or pharmacological agents underlies cognitive effects of aerobic activity (Kobilo et al., 2011; Figure 1). Our work was based on the findings that peroxisome proliferator activated receptor δ (PPARδ) regulates muscle fiber contraction and metabolism (Wang et al., 2004; Narkar et al., 2008). PPARδ is regulated by AMP-activated protein kinase (AMPK), a master metabolic regulator important for exercise physiology (Hardie, 2004). Treatment with AMPK agonist 5-Aminoimidazole-4-carboxamide-1β-d-ribofuranoside (AICAR) enhanced endurance in sedentary mice (Narkar et al., 2008). We showed that the effects of activation of AMPK and PPARδ extend from the periphery to brain. AICAR had robust effects on memory, cell proliferation, and hippocampal neurogenesis, consistent with its endurance phenotype (Figure 1). The PPARδ agonist GW501516 was less effective than AICAR reflecting its modest “exercise” phenotype (Kobilo et al., 2011). Narkar et al. (2008) showed that GW treatment increased running endurance only when it was paired with training. Interestingly, the effects of AICAR were dependent on the duration of administration, as 7 days of treatment enhanced adult neurogenesis and memory function, but A commentary on